SWTX
SpringWorks Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -23.1% ·
flujo de acciones -18.8% ·
nuevas posiciones netas -20.0%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2025 | 16 | -1 | 23.61M | $1.11B | +1 | −2 |
| Q1 2025 | 14 | +4 | 11.91M | $525.67M | +4 | — |
| Q4 2024 | 10 | -3 | 10.41M | $375.97M | — | −3 |
| Q3 2024 | 12 | 0 | 9.81M | $314.31M | — | — |
| Q2 2024 | 12 | — | 10.32M | $388.74M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.27M | -6.9% | $118.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.27M | -6.9% | $118.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.00M | — | $108.43M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.67M | 0.0% | $60.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.67M | 0.0% | $60.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Duquesne Family Office ✦ | 859.69K | +21.9% | $31.06M | 0.9% | ▲ Add | 3 | SEC ↗ |
| 7 | Soros Fund Management ✦ | 600.47K | +7.4% | $21.69M | 0.5% | ▲ Add | 3 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 387.73K | -46.5% | $14.01M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 373.23K | +185.6% | $13.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 373.23K | +185.6% | $13.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Norges Bank ✦ (pasivo) | 186.50K | -20.1% | $6.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 31.18K | -10.9% | $1.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 31.18K | -10.9% | $1.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 31.18K | -10.9% | $1.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 31.18K | -10.9% | $1.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 20.88K | -52.5% | $754,431 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 20.88K | -52.5% | $754,431 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 20.88K | -52.5% | $754,431 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Marshall Wace | $62.86M | era 0.1% |
| Two Sigma Investments | $4.91M | era 0.0% |
| Millennium Management | $2.42M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 1 acciones, $47 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.